T. Nagai et al.
Bull. Chem. Soc. Jpn., 74, No. 9 (2001) 1677
of 8 (10 mmol) in THF (30 mL). The mixture was stirred for 15 h.
After normal workup, the product was separated by column chro-
matography (SiO2, hexane–EtOAc, 4:1) to give 5-1 (309 mg,
38%) and 6 (283 mg, 23%) as colorless needles, mp 175–176 °C.
1H NMR (CDCl3) δ 1.35 (s, 6 H), 1.74 (s, 2 H), 1.89 (d, J = 13.9
Hz, 2H), 2.76 (d, J = 13.9 Hz, 2H), 2.93 (s, 12H), 6.63 (d, J = 9.0
Hz, 4 H), 7.08 (d, J = 9.0 Hz, 4 H); IR (KBr) 3535, 3285, 2947,
2864, 1610, 1516, 1475, 1440, 1336, 1199, 1142, 1055, 967, 936,
5.1, 3.6 Hz, 1 H), 7.12 (dd, J = 5.1, 1.1 Hz, 1 H), 7.15 (d, J = 8.6
Hz, 2 H); IR (KBr) 2928, 2810, 1620, 1525, 1445, 1364, 1228,
1197, 814 cm−1; MS m/z 295 (M+; 100), 280 (M+−Me; 60), 266
(8), 250 (4), 235 (10), 221 (12). HRMS Found: m/z 295.13981.
Calcd for C19H21NS: M, 295.13947.
Synthesis of 3e. A solution of 7-1 (229 mg, 1.0 mmol) in
THF (3 mL) was added dropwise at −78 °C to a solution of 2-
lithiobenzofuran (9, 2 mmol) in ether (2 mL) and stirred for 15
min at this temperature. The mixture was poured into ice-water
and extracted with EtOAc. The organic layer was washed with
brine, dried over anhydrous MgSO4, and concentrated in vacuo. A
mixture of the crude product and p-TsOH (190 mg, 1 mmol) in
toluene (10 mL) was refluxed for 15 min. After normal workup,
the product was separated by column chromatography (SiO2, hex-
ane–EtOAc, 20:1) to give 3e (243.3 mg, 74.0%) as slightly yellow
viscous oil (sensitive to air). 1H NMR (CDCl3) δ 1.33 (s, 6 H),
2.99 (s, 6 H), 6.16 (d, J = 2.6 Hz, 1 H), 6.19 (s, 1H), 6.74 (d, J =
8.9 Hz, 2 H), 6.85 (d, J = 2.6 Hz, 1 H), 6.89 (dd, J = 5.1, 3.6 Hz,
1 H), 7.04–7.32 (m, 2 H), 7.26 (d, J = 8.9 Hz, 2 H), 7.37–7.48 (m,
2 H); IR (KBr) 2960, 2859, 1612, 1512, 1450, 1352, 1256, 1163,
814 cm−1; MS m/z 329 (M+; 100), 314 (M+−Me; 45), 300 (6),
284 (3), 255 (9). HRMS Found: m/z 329.17769. Calcd for
C23H23NO: M, 329.17796.
819 cm−1
.
Found: C, 74.87; H, 8.79; N, 7.61%. Calcd for
C23H32N2O2: C, 74.96; H, 8.77; N, 7.60%.
Synthesis of 3b. A solution of 6 (282 mg, 0.76 mmol) and p-
TsOH•H2O (260 mg, 1.37 mmol) in toluene (10 mL) was refluxed
for 30 min. The mixture was poured into 10% NaOH solution and
extracted with ether. The ether layer was washed with brine, and
dried over anhydrous MgSO4. After evaporation of the solvent,
the product was separated by column chromatography (SiO2, hex-
ane–EtOAc, 10:1) to give 3b (156 mg, 86%) as slightly yellow
needles (sensitive to air). 1H NMR (CDCl3) δ 1.28 (s, 6 H), 2.93
(s, 12H), 6.19 (s, 2 H), 6.65 (d, J = 8.9 Hz, 4 H), 7.08 (d, J = 8.9
Hz, 4 H); IR (KBr) 2950, 2858, 1617, 1516, 1352, 1225, 1195,
814 cm−1; MS m/z 332 (M+; 20), 317 (M+−Me; 9), 295 (4), 281
(14), 264 (4). HRMS Found: m/z 332.22434. Calcd for
C23H28F6N2:M, 332.22525.
Synthesis of 4,4-Dimethyl-2-[4-(dimethylamino)phenyl]-2-
cyclopenten-1-one (7-1). A solution of 5-1 (1.31 g, 5.3 mmol)
and p-TsOH•H2O (1.11 g, 5.8 mmol) in toluene (50 mL) was re-
fluxed for 20 min. After normal workup, the product was separat-
ed by column chromatography (SiO2, hexane–EtOAc, 10:1) to
give 7-1 (1.089 g, 89.7%) as colorless needles, mp 87–88 °C. 1H
NMR (CDCl3) δ 1.27 (s, 6 H), 2.44 (s, 2 H), 2.97 (s, 6 H), 6.72 (d,
J = 9.1 Hz, 2 H), 7.41 (s, 1H), 7.65 (d, J = 9.1 Hz, 2 H); IR (KBr)
2962, 1695, 1614, 1522, 1360, 819 cm−1. Found: C, 78.76; H,
8.14; N, 5.99%. Calcd for C15H19NO: C, 78.56; H, 8.35; N,
6.11%.
Synthesis of 3c. A solution of 7-1 (229 mg, 1.0 mmol) in
THF (3 mL) was added dropwise at 0 °C to a solution of Grignard
reagent, which was formed by treatment of Mg (36.3 mg, 1.5
mmol) with 4-bromoanisole (280.6 mg, 1.5 mmol) in THF (2 mL),
and stirred for 19 h at room temperature. After normal workup,
the product was separated by column chromatography (SiO2, hex-
ane–EtOAc, 10:1) to give 7-1 (25.7 mg 11.2%) and 3c (72.5 mg,
22.3%) as slightly yellow viscous oil (sensitive to air). 1H NMR
(CDCl3) δ 1.29 (s, 6 H), 2.93 (s, 6 H), 3.79 (s, 3 H), 6.20 (d, J =
2.6 Hz, 1 H), 6.22 (d, J = 2.6 Hz, 1 H), 6.62 (d, J = 8.8 Hz, 2 H),
6.78 (d, J = 8.9 Hz, 2 H), 7.04 (d, J = 8.9 Hz, 2 H), 7.12 (d, J =
8.8 Hz, 2 H); IR (KBr) 2957, 1609, 1508, 1351, 1245, 1176, 1039,
821 cm−1; MS m/z 319 (M+; 100), 304 (M+−Me; 57), 290 (7),
274 (3), 245 (5), 214 (20). HRMS Found: m/z 319.19425. Calcd
for C22H25NO:M, 319.19361.
Synthesis of 3d. A solution of 7-1 (229 mg, 1.0 mmol) in
THF (3 mL) was added dropwise at −78 °C to a solution of 2-
lithiothiophene (3 mmol) in THF (3 mL) and stirred for 1 h at
room temperature. The mixture was poured into ice-water and ex-
tracted with EtOAc. The organic layer was washed with brine,
dried over anhydrous MgSO4, and concentrated in vacuo. A mix-
ture of the crude product and p-TsOH (190 mg, 1 mmol) in tolu-
ene (10 mL) was refluxed for 15 min. After normal workup, the
product was separated by column chromatography (SiO2, hexane–
EtOAc, 20:1) to give 3d (175.1 mg, 59.4%) as slightly yellow
needles (sensitive to air). 1H NMR (CDCl3) δ 1.29 (s, 6 H), 2.97
(s, 6 H), 6.17 (d, J = 2.5 Hz, 1 H), 6.40 (d, J = 2.5 Hz, 1 H), 6.63
(dd, J = 1.1, 3.6 Hz, 1 H), 6.70 (d, J = 8.6 Hz, 2 H), 6.89 (dd, J =
Synthesis of 3f. Synthesis of (2-Benzofuryl)-2-hydroxy-4,4-
dimethylcylopentan-1-one (5-2). A solution of 4 (9.0 g, 71
mmol) in THF (80 mL) was added dropwise at 0 °C to a solution
of 9 (237 mmol) in ether (240 mL). The mixture was stirred for 1
h at room temperature. After normal workup, the product was
separated by column chromatography (SiO2, hexane–EtOAc,
10:1–5:1) to give 5-2 (16.94 g, 85.8%) as colorless viscous oil.
1H NMR (CDCl3) δ 1.18 (s, 3 H), 1.21 (s, 3 H), 2.21 (dd, J = 14.3,
1.7 Hz, 1H), 2.37 (dd, J = 17.4, 1.7 Hz, 1H), 2.60 (d, J = 17.4 Hz,
1H), 2.63 (d, J = 14.3 Hz, 1H), 3.32 (s, 1 H), 6.69 (d, J = 0.9 Hz,
1 H), 7.15–7.35 (m, 2 H), 7.42–7.55 (m, 2 H); IR (neat) 3348,
2959, 1752, 1457, 1251 cm−1 ; MS m/z 244 (M+; 11), 226 (M+−
H2O; 45), 211 (M+−H2O−Me; 42), 183 (39), 160 (83). HRMS
Found: m/z 244.11034. Calcd for C15H16O3: M, 244.10994.
Synthesis of 2-(2-Benzofuryl)-4,4-dimethyl-2-cyclopenten-
1-one (7-2). A solution of 5-2 (6.49 g, 26.6 mmol) and p-
TsOH•H2O (465 mg, 2.7 mmol) in toluene (260 mL) was refluxed
for 40 min. After normal workup, the product was separated by
column chromatography (SiO2, hexane–EtOAc, 20:1) to give 7-2
(4.66 g, 77.4%) as colorless needles, mp 65–66 °C. 1H NMR
(CDCl3) δ 1.33 (s, 6 H), 2.48 (s, 2 H), 2.97 (s, 6 H), 7.22 (dd, J =
7.2, 1.3 Hz, 1 H), 7.30 (dd, J = 7.7, 1.6 Hz, 1 H), 7.42–7.49 (m, 2
H), 7.57–7.63 (m, 1 H), 7.80 (s, 1H); IR (neat) 2956, 1713, 1449,
1364, 1250, 1112 cm−1. Found: C, 79.57; H, 6.26%. Calcd for
C23H32N2O2: C, 79.62; H, 6.24; N.
Synthesis of 3f. A solution of 7-2 (485 mg, 2.1 mmol) in
THF (3 mL) was added dropwise at −78 °C to a solution of 9 (4.2
mmol) in ether (5 mL) and stirred for 1 h at room temperature.
The mixture was poured into ice-water and extracted with EtOAc.
The organic layer was washed with brine, dried over anhydrous
MgSO4, and concentrated in vacuo. A mixture of the crude prod-
uct and p-TsOH (5 mg, 0.026 mmol) in toluene (10 mL) was re-
fluxed for 30 min. After normal workup, the product was separat-
ed by column chromatography (SiO2, hexane–EtOAc, 50:1) to
give 3f (547 mg, 79.9%) as slightly yellow viscous oil (sensitive to
air). 1H NMR (CDCl3) δ 1.38 (s, 6 H), 6.70 (d, J = 0.9 Hz, 2 H),
6.82 (s, 2 H), 7.17–7.34 (m, 4 H), 7.45–7.64 (m, 4 H); IR (neat)
2962, 1451, 1256, 749 cm−1; MS m/z 326 (M+; 100), 311 (M+−
Me; 35), 297 (5), 281 (5), 252 (5), 239 (9). HRMS Found: m/z